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Abstract
Background: Genetic association study is currently the primary vehicle for identification and characterization of
disease-predisposing variant(s) which usually involves multiple single-nucleotide polymorphisms (SNPs) available.
However, SNP-wise association tests raise concerns over multiple testing. Haplotype-based methods have the
advantage of being able to account for correlations between neighbouring SNPs, yet assuming Hardy-Weinberg
equilibrium (HWE) and potentially large number degrees of freedom can harm its statistical power and robustness.
Approaches based on principal component analysis (PCA) are preferable in this regard but their performance varies
with methods of extracting principal components (PCs).
Results: PCA-based bootstrap confidence interval test (PCA-BCIT), which directly uses the PC scores to assess gene-
disease association, was developed and evaluated for three ways of extracting PCs, i.e., cases only(CAES), controls
only(COES) and cases and controls combined(CES). Extraction of PCs with COES is preferred to that with CAES and
CES. Performance of the test was examined via simulations as well as analyses on data of rheumatoid arthritis and
heroin addiction, which maintains nominal level under null hypothesis and showed comparable performance with
permutation test.
Conclusions: PCA-BCIT is a valid and powerful method for assessing gene-disease association involving multiple
SNPs.
Background
Genetic association studies now customarily involve
multiple SNPs in candidate genes or genomic regions
and have a significant role in identifying and character-
izing disease-predisposing variant(s). A critical challenge
in their statistical analysis is how to make optimal use
of all available information. Population-based case-con-
trol studies have been very popular[1] and typically
involve contingency table tests of SNP-disease associa-
tion[2]. Notably, the genotype-wise Armitage trend test
does not require HWE and has equivalent power to its
allele-wise counterpart under HWE[3,4]. A thorny issue
with individual tests of SNPs for linkage disequilibrium
(LD) in such setting is multiple testing, however, meth-
ods for multiple testing adjustment assuming indepen-
dence such as Bonferroni’s[5,6] is knowingly
conservative[7]. It is therefore necessary to seek alterna-
tive approaches which can utilize multiple SNPs simul-
taneously. The genotype-wise Armitage trend test is
appealing since it is equivalent to the score test from
logistic regression[8] of case-control status on dosage of
disease-predisposing alleles of SNP. However, testing for
the effects of multiple SNPs simultaneously via logistic
regression is no cure for difficulty with multicollinearity
and curse of dimensionality[9]. Haplotype-based meth-
ods have many desirable properties[10] and could possi-
bly alleviate the problem[11-14], but assumption of
HWE is usually required and a potentially large number
of degrees of freedom are involved[7,11,15-18].
It has recently been proposed that PCA can be com-
bined with logistic regression test (LRT)[7,16,17] in a
unified framework so that PCA is conducted first to
account for between-SNP correlations in a candidate
region, then LRT is applied as a formal test for the
association between PC scores (linear combinations of
the original SNPs) and disease. Since PCs are orthogo-
nal, it avoids multicollinearity and at the meantime is
* Correspondence: jinghua.zhao@mrc-epid.cam.ac.uk; xuefzh@sdu.edu.cn
1Department of Epidemiology and Health Statistics, School of Public Health,
Shandong University, Jinan 250012, PR China
2MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s
Hospital, Cambridge CB2 0QQ, UK
Peng et al. BMC Genetics 2010, 11:6
http://www.biomedcentral.com/1471-2156/11/6
© 2010 Peng et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
less computer-intensive than haplotype-based methods.
Studies have shown that PCA-LRT is at least as power-
ful as genotype- and haplotype-based methods[7,16,17].
Nevertheless, the power of PCA-based approaches vary
with ways by which PCs are extracted, e.g., from geno-
type correlation, LD, or other kinds of metrics[17], and
in principle can be employed in frameworks other than
logistic regression[7,16,17]. Here we investigate ways of
extracting PCs using genotype correlation matrix from
different types of samples in a case-control study,
while presenting a new approach testing for gene-dis-
ease association by direct use of PC scores in a PCA-
based bootstrap confidence interval test (PCA-BCIT).
We evaluated its performance via simulations and
compared it with PCA-LRT and permutation test using
real data.
Methods
PCA
Assume that p SNPs in a candidate region of interest
have coded values (X1, X2, ..., Xp) according to a given
genetic model (e.g., additive model) whose correlation
matrix is C. PCA solves the following equation,
Cl li i  0 (1)
where l li i = 1, i = 1,2, ..., p, li = (li1, li2, ..., lip)’ are
loadings of PCs. The score for an individual subject is
F l X l X l X i pi i i ip p    1 1 2 2 1 2 , , , , , (2)
where cov (Fi, Fj) = 0, i ≠ j, and var(F1) ≥ var(F2) ≥ ...
≥ var(Fp).
Methods of extracting PCs
Potentially, PCA can be conducted via four distinct
extracting strategies (ES) using case-control data, i.e., 0.
Calculate PC scores of individuals in cases and controls
separately (SES), 1. Use cases only (CAES) to obtain
loadings for calculation of PC scores for subjects in both
cases and controls, 2. Use controls only (COES) to
obtain the loadings for both groups, and 3. Use com-
bined cases and controls (CES) to obtain the loadings
for both groups. It is likely that in a case-control asso-
ciation study, loadings calculated from cases and con-
trols can have different connotations and hence we only
consider scenarios 1-3 hereafter. More formally, let (X1,
X2, ..., Xp) and (Y1, Y2, ..., Yp) be p-dimension vectors of
SNPs at a given candidate region for cases and controls
respectively, then we have,
Strategy 1 (CAES):
C l lXX i i
1 1 0  (3)
where CXX is the correlation matrix of (X1, X2, ..., Xp),
l l l li i i ip
1
1
1
2
1 1 ( , , , ) and l li i1 1 = 1, i = 1,2, ..., p. The ith
PC for cases is calculated by
F l X l X l Xi
D
i i ip p   11 1 21 2 1 (4)
and for controls
F l Y l Y l Yi
C
i i ip p   11 1 21 2 1 (5)
Strategy 2 (COES):
C l lYY i i  0 (6)
where CYY is the correlation matrix of (Y1, Y2, ..., Yp).
The ith PC for controls is calculated by
F l Y l Y l Yi
C
i i ip p   1 1 2 2  (7)
And for cases, the ith PC, i = 1,2, ..., p, is calculated by
F l X l X l Xi
D
i i ip p   1 1 2 2  (8)
Strategy 3 (CES):
Cl li i
   0 (9)
where C is the correlation matrix obtained from the
pooled data of cases and controls,     l l l li i i ip ( , , , )1 2
and   l l i pi i  1 1 2, , , , . The ith PC of cases is calcu-
lated by
F l X l X l Xi
D
i i ip p      1 1 2 2 (10)
The ith PC of controls is calculated by
F l Y l Y l Yi
C
i i ip p      1 1 2 2 (11)
PCA-BCIT
Given a sample of N cases and M controls with p-SNP
genotypes (X1, X2, ..., XN)
T, (Y1, Y2, ..., YM)
T, and Xi =
(X1i, X2i, ..., xpi) for the i
th case, Yi = (Y1i, Y2i, ..., ypi) for
the ith control, a PCA-BCIT is furnished in three steps:
Step 1: Sampling
Replicate samples of cases and controls are obtained
with replacement separately from (X1
(b, X2
(b), ..., XN
(b))T
and (Y1
(b, Y2
(b), ..., YM
(b))T, b = 1,2, ..., B (B = 1000).
Step 2: PCA
For each replicate sample obtained at Step 1, PCA is
conducted and a given number of PCs retained with a
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threshold of 80% explained variance for all three strate-
gies[16], expressed as F F FD D KD
b
1 2, , ,
( )  and F F FC C KC b1 2, , , ( )  .
Step 3: PCA-BCIT
3a) For each replicate, the mean of the kth PC in cases is
calculated by
mean F
N
Fk
D b
ki
D b
i
N
( )( ) ( )

1
1
(12)
and that of the kth PC in controls is calculated by
mean F
M
Fk
C b
kj
C b
j
M
( )( ) ( )

1
1
(13)
3b) Given confidence level (1 - a ), the confidence
interval of mean Fk
D b( )( ) is estimated by percentile
method, with form
( , )
( )
P P
k
D
k
D 
2 2
1
 for case (14)
where Pk
D
2
is the 100 2
 th percentile of
mean Fk
D b( )( ) , and Pk
D
( )1
2
 is the 100 1 2( )  th
percentile.
The confidence interval of mean Fk
C b( )( ) is estimated
by
( , )
( )
P P
k
C
k
C 
2 2
1
 for control (15)
where Pk
C
2
is the 100 2
 th percentile of
mean Fk
C b( )( ) , and Pk
C
( )1
2
 is the 100 1 2( )  th
percentile.
3c) Confidence intervals of cases and controls are
compared. The null hypothesis is rejected if
( , )
( )
P P
k
D
k
D 
2 2
1 and ( , )( )P Pk
C
k
C 
2 2
1 do not overlap,
which is mean Fk
D b( )( ) and mean Fk
C b( )( ) are statistically
different[19], indicating the candidate region is signifi-
cantly associated with disease at level a. Otherwise, the
candidate region is not significantly associated with dis-
ease at level a.
Simulation studies
We examine the performance of PCA-BCIT through
simulations with data from the North American Rheu-
matoid Arthritis (RA) Consortium (NARAC) (868 cases
and 1194 controls)[20], taking advantage of the fact that
association between protein tyrosine phosphatase non-
receptor type 22 (PTPN22) and the development of RA
has been established[21-24]. Nine SNPs have been
selected from the PNPT22 region (114157960-
114215857), and most of the SNPs are within the same
LD block (Figure 1). Females are more predisposed
(73.85%) and are used in our simulation to ensure
homogeneity. The corresponding steps for the simula-
tion are as follows.
Step 1: Sampling
The observed genotype frequencies in the study sample
are taken to be their true frequencies in populations of
infinite sizes. Replicate samples of cases and controls of
given size (N, N = 100, 200, ..., 1000) are generated
whose estimated genotype frequencies are expected to
be close to the true population frequencies while both
the allele frequencies and LD structure are maintained.
Under null hypothesis, replicate cases and controls are
sampled with replacement from the controls. Under
alternative hypothesis, replicate cases and controls are
sampled with replacement from the cases and controls
respectively.
Step 2: PCA-BCITing
For each replicate sample, PCA-BCITs are conducted
through the three strategies of extracting PCs as out-
lined above on association between PC scores and dis-
ease (RA).
Step 3: Evaluating performance of PCA-BCITs
Repeat steps 1 and 2 for K ( K = 1000 ) times under
both null and alternative hypotheses, and obtain the fre-
quencies (Pa) of rejecting null hypothesis at level a (a =
0.05).
Applications
PCA-BCITs are applied to both the NARAC data on
PTPN22 in 1493 females (641 cases and 852 controls)
described above and a data containing nine SNPs near
μ-opioid receptor gene (OPRM1) in Han Chinese from
Shanghai (91 cases and 245 controls) with endopheno-
type of heroin-induced positive responses on first use
[25]. There are two LD blocks in the region of gene
OPRM1 (Figure 2).
Results
Simulation study
The performance of PCA-BCIT is shown in Table 1 for
the three strategies given a range of sample sizes. It can
be seen that strategies 2 and 3 both have type I error
rates approaching the nominal level (a = 0.05), but
those from strategy 1 deviate heavily. When sample size
larger than 800, the power of PCA-BCIT is above 0.8,
and strategies 2 and 3 outperform strategy 1 slightly.
Applications
For the NARAC data, Armitage trend test reveals none
of the SNPs in significant association with RA using
Bonferroni correction (Table 2), but the results of PCA-
BCIT with strategies 2 and 3 show that the first PC
Peng et al. BMC Genetics 2010, 11:6
http://www.biomedcentral.com/1471-2156/11/6
Page 3 of 8
Figure 1 LD (r2) among nine PTPN22 SNPs. The nine PTPN22 SNPs are rs971173, rs1217390, rs878129, rs11811771, rs11102703, rs7545038,
rs1503832, rs12127377, rs11485101. The triangle marks a single LD block within this region: (rs878129, rs11811771, rs11102703, rs7545038,
rs1503832, rs12127377, rs11485101).
Figure 2 LD (r2) among nine OPRM1 SNPs. The nine OPRM1 SNPs are rs1799971, rs510769, rs696522, rs1381376, rs3778151, rs2075572,
rs533586, rs550014, rs658156. The triangles mark the LD block 1 (rs696522, rs1381376, rs3778151) and LD block 2 (rs550014, rs658156).
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extracted in region of PTPN22 is significantly associated
with RA. The results are similar to that from permuta-
tion test (Table 3).
For the OPRM1 data, the sample characteristics are
comparable between cases and controls (Table 4), and
three SNPs (rs696522, rs1381376 and rs3778151) are
showed significant association with the endophenotype
(Table 5). The results of PCA-BCIT with strategies 2
and 3 and permutation test are all significant at level a
= 0.01. In contrast, result from PCA-LRT is not signifi-
cant at level a = 0.05 with strategy 2 (Table 3). The
apparent separation of cases and controls are shown in
Figure 3 for PCA-BCIT with strategy 3, suggesting an
intuitive interpretation.
Discussion
In this study, a PCA-based bootstrap confidence interval
test[19,26-28] (PCA-BCIT) is developed to study gene-
disease association using all SNPs genotyped in a given
region. There are several attractive features of PCA-
Table 1 Performance of PCA-BCIT at level 0.05 with
strategies 1-3†
Sample size Type I error Power
1 2 3 1 2 3
100 0.014 0.036 0.037 0.156 0.163 0.176
200 0.016 0.044 0.036 0.249 0.278 0.292
300 0.017 0.028 0.029 0.383 0.426 0.368
400 0.014 0.04 0.02 0.508 0.485 0.516
500 0.009 0.035 0.042 0.613 0.595 0.597
600 0.006 0.032 0.042 0.677 0.662 0.683
700 0.007 0.061 0.04 0.733 0.758 0.73
800 0.004 0.043 0.045 0.801 0.791 0.819
900 0.005 0.057 0.051 0.826 0.855 0.858
1000 0.01 0.056 0.05 0.871 0.901 0.889
†1 case-only extracting strategy (CAES), 2 control-only extracting strategy
(COES), 3 case-control extracting strategy (CES)
Table 2 Armitage trend test on nine PTPN22 SNPs and RA susceptibility
SNP Genotype Female Male
Case Control P-value Case control P-value
rs971173 CC 334 381 0.025 116 169 0.779
AC 236 363 85 134
AA 71 106 26 39
rs1217390 AA 268 319 0.333 99 112 0.108
AG 272 392 89 175
GG 98 138 38 55
rs878129 GG 338 507 0.009 131 187 0.384
AG 251 291 83 130
AA 52 54 13 25
rs11811771 AA 224 272 0.090 78 111 0.717
AG 303 411 104 168
GG 112 169 45 62
rs11102703 CC 312 469 0.024 121 174 0.418
AC 269 314 90 137
AA 60 69 16 31
rs7545038 GG 321 428 0.696 109 186 0.417
AG 265 342 98 114
AA 52 80 20 40
rs1503832 AA 324 487 0.013 129 185 0.249
AG 262 306 86 127
GG 55 59 12 30
rs12127377 AA 349 521 0.017 139 197 0.230
AG 243 282 78 121
GG 49 48 10 24
rs11485101 AA 564 738 0.656 206 305 0.430
AG 72 112 21 35
GG 5 2 0 2
None of the P-values is significant after Bonferroni Correction.
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based approaches. First of all, they are at least as power-
ful as genotype- and haplotype-based methods[7,16,17].
Secondly, they are able to capture LD information
between correlated SNPs and easy to compute with
needless consideration of multicollinearity and multiple
testing. Thirdly, BCIT integrates point estimation and
hypothesis testing as a single inferential statement of
great intuitive appeal[29] and does not rely on the distri-
butional assumption of the statistic used to calculate
confidence interval[19,26-29].
While there have been several different but closely
related forms of bootstrap confidence interval calcula-
tions[28], we focus on percentiles of the asymptotic
distribution of PCs for given confidence levels to esti-
mate the confidence interval. PCA-BCIT is a data-
learning method[29], and shown to be valid and
powerful for sufficiently large number of replicates in
our study. Our investigation involving three strategies
of extracting PCs reveals that strategy 1 is invalid,
while strategies 2 and 3 are acceptable. From analyses
of real data we find that PCA-BCIT is more favourable
compared with PCA-LRT and permutation test. It is
suggested that a practical advantage of PCA-BCIT is
that it offers an intuitive measure of difference
between cases and controls by using the set of SNPs
(PC scores) in a candidate region (Figure 3). As extrac-
tion of PCs through COES is more in line with the
principle of a case-control study, it will be our method
of choice given that it has a comparable performance
with CES. Nevertheless, PCA-BCIT has the limitation
that it does not directly handle covariates as is usually
done in a regression model.
Conclusions
PCA-BCIT is both a valid and a powerful PCA-based
method which captures multi-SNP information in study
of gene-disease association. While extracting PCs based
on CAES, COES and CES all have good performances, it
appears that COES is more appropriate to use.
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Table 3 PCA-BCIT, PCA-LRT and permutation test on real data
Study Strategy† 99%CI 95%CI P-value‡
PCA-LRT Permutation test
PTPN22 2 (-5.4E-01,-4.7E-03)**
(-7.5E-16,6.9E-16)
(-4.8E-01,-8.6E-02)*
(-4.6E-16,4.2E-16)
0.006** 0.002**
3 (1.7E-02,3.3E-01)**
(-2.5E-01,-1.3E-02)
(4.9E-02,3.0E-01)*
(-2.2E-01,-3.7E-02)
0.007** 0.002**
OPRM1 2 (-1.2E+00,-1.1E-02)**
(-4.7E-16,5.0E-16)
(-1.1E+00,-1.8E-01)*
(-3.7E-16,3.4E-16)
0.107 0.002**
3 (5.3E-02,1.4E+00)**
(-4.9E-01,-1.7E-02)
(2.4E-01,1.2E+00)*
(-4.2E-01,-8.0E-02)
0.012* 0.004**
†2 control-only extracting strategy (COES), 3 case-control extracting strategy (CES)
‡* significant at levels a = 0.05(*) and a = 0.01 (**).
Table 4 Sample characteristics of heroin-induced positive responses on first use
Cases (N = 91) Controls (N = 245) P-value
Age (yrs) 30.42 ± 7.65 30.93 ± 8.18 0.6057
Women (%) 26.4 29.8 0.5384
Age at onset (yrs) 26.29 ± 7.41 26.97 ± 7.89 0.4760
Reason for first use of heroin 0.7173
Curiousness 79.1 75.1
Peer pressure 6.6 4.9
Physical disease 7.7 10.2
Trouble 5.5 6.1
Other reasons 1.1 3.8
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Table 5 Armitage trend tests on nine OPRM1 SNPs and heroin-induced positive responses on first use
SNP Genotype Count and frequency Armitage trend test
Cases Controls Chi-square P-value
rs1799971 AA 55 0.604 150 0.622 0.003 0.9537
AG 27 0.297 64 0.266
GG 9 0.099 24 0.112
rs510769 TT 56 0.667 167 0.749 2.744 0.0976
TC 24 0.286 53 0.237
CC 4 0.048 4 0.018
rs696522 AA 64 0.762 215 0.907 11.097 0.0009*
AG 19 0.226 21 0.089
GG 1 0.012 1 0.004
rs1381376 CC 70 0.769 221 0.913 13.409 0.0003*
CT 20 0.220 21 0.087
TT 1 0.011 0 0.000
rs3778151 GG 66 0.733 215 0.896 14.655 0.0001*
GA 23 0.256 25 0.104
AA 1 0.011 0 0.000
rs2075572 GG 50 0.556 149 0.642 1.574 0.2096
GC 33 0.367 82 0.353
CC 7 0.078 11 0.047
rs533586 TT 68 0.840 203 0.868 0.761 0.3830
TC 12 0.148 31 0.132
CC 1 0.012 0 0.000
rs550014 TT 78 0.857 203 0.832 0.093 0.7602
TC 12 0.132 41 0.168
CC 1 0.011 0 0.000
rs658156 GG 65 0.714 192 0.787 2.041 0.1531
GA 24 0.264 52 0.213
AA 1 0.011 0 0.000
* significant after Bonferroni Correction.
Figure 3 Real data analyses by PCA-BCIT with strategy 3 and confidence level 0.95. The horizontal axis denotes studies and vertical axis
mean(PC1), the statistic used to calculate confidence intervals for cases and controls. PCA-BCITs with strategy 3 were significant at confidence
level 0.95.
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